1.
临床病理参数与Survivin自身抗体表达之间的关系
The relationship between clinicopathological parameters and the expression of anti-Survivin antibody in NSCLC
| Clinical characteristics | Positive (n) | Negative (n) | Total | χ2 | P |
| *: P < 0.05. | |||||
| Age (yrs) | 1.559 | 0.239 | |||
| < 60 | 18 | 88 | 106 | ||
| ≥60 | 26 | 83 | 109 | ||
| Gender | 0.111 | 0.856 | |||
| Male | 31 | 116 | 147 | ||
| Female | 13 | 55 | 68 | ||
| Smoking status | 1.900 | 0.229 | |||
| Smoking | 30 | 97 | 127 | ||
| Non-smoking | 14 | 74 | 88 | ||
| Pathological type | 0 | 1.000 | |||
| Squamous cell carcinoma | 17 | 66 | 83 | ||
| Adenocarcinoma | 27 | 105 | 132 | ||
| Primary tumor | 13.60 | < 0.001* | |||
| < 3 cm | 10 | 91 | 101 | ||
| ≥3 cm | 34 | 80 | 114 | ||
| Lymphatic metastasis | 1.792 | 0.235 | |||
| No | 24 | 74 | 98 | ||
| Yes | 20 | 97 | 117 | ||
| Distant metastasis No | 34 | 100 | 134 | 5.264 | 0.024* |
| Yes | 10 | 71 | 81 | ||
| Stage | 0.577 | 0.442 | |||
| Ⅰ/Ⅱ | 13 | 41 | 44 | ||
| Ⅲ/Ⅳ | 31 | 130 | 161 | ||